Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / / Veysel Kayser.

Show other versions (1)

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each p...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Kayser, Veysel,
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (298 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993562207304498
ctrlnum (CKB)4920000001372291
(NjHacI)994920000001372291
(EXLCZ)994920000001372291
collection bib_alma
record_format marc
spelling Kayser, Veysel, author.
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Veysel Kayser.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (298 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on online resource; title from PDF title page (MDPI - Multidisciplinary Digital Publishing Institute, viewed February 24, 2023).
The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.
English.
Monoclonal antibodies Therapeutic use.
3-0365-2686-2
language English
format eBook
author Kayser, Veysel,
spellingShingle Kayser, Veysel,
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
author_facet Kayser, Veysel,
author_variant v k vk
author_role VerfasserIn
author_sort Kayser, Veysel,
title Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_full Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Veysel Kayser.
title_fullStr Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Veysel Kayser.
title_full_unstemmed Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Veysel Kayser.
title_auth Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_new Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_sort therapeutic monoclonal antibodies and antibody products, their optimization and drug design in cancers /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (298 pages)
isbn 3-0365-2686-2
callnumber-first R - Medicine
callnumber-subject RM - Therapeutics and Pharmacology
callnumber-label RM282
callnumber-sort RM 3282 M65 K397 42022
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.37
dewey-sort 3615.37
dewey-raw 615.37
dewey-search 615.37
work_keys_str_mv AT kayserveysel therapeuticmonoclonalantibodiesandantibodyproductstheiroptimizationanddrugdesignincancers
status_str n
ids_txt_mv (CKB)4920000001372291
(NjHacI)994920000001372291
(EXLCZ)994920000001372291
carrierType_str_mv cr
is_hierarchy_title Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
_version_ 1764993913692618752
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01667nam a2200301 i 4500</leader><controlfield tag="001">993562207304498</controlfield><controlfield tag="005">20230225095127.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230225s2022 sz o u000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372291</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372291</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="1" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM282.M65</subfield><subfield code="b">.K397 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.37</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kayser, Veysel,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /</subfield><subfield code="c">Veysel Kayser.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (298 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (MDPI - Multidisciplinary Digital Publishing Institute, viewed February 24, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Monoclonal antibodies</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2686-2</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 01:51:16 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338132750004498&amp;Force_direct=true</subfield><subfield code="Z">5338132750004498</subfield><subfield code="8">5338132750004498</subfield></datafield></record></collection>

Similar Items